A detailed history of Man Group PLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Man Group PLC holds 1,826,280 shares of MRK stock, worth $181 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
1,826,280
Previous 1,935,509 5.64%
Holding current value
$181 Million
Previous $240 Million 13.45%
% of portfolio
0.58%
Previous 0.64%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $12.1 Million - $14.1 Million
-109,229 Reduced 5.64%
1,826,280 $207 Million
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $2.37 Million - $2.54 Million
-19,114 Reduced 0.98%
1,935,509 $240 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $120 Million - $140 Million
1,060,236 Added 118.54%
1,954,623 $258 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $68.5 Million - $74.5 Million
683,710 Added 324.53%
894,387 $97.5 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $1.53 Million - $1.7 Million
-14,907 Reduced 6.61%
210,677 $21.7 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $4.27 Million - $4.65 Million
-39,317 Reduced 14.84%
225,584 $26 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $55.4 Million - $61.8 Million
-538,117 Reduced 67.01%
264,901 $28.2 Million
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $2 Million - $2.57 Million
22,898 Added 2.94%
803,018 $89.1 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $54,944 - $61,723
650 Added 0.08%
780,120 $67.2 Million
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $28.2 Million - $32 Million
-338,175 Reduced 30.26%
779,470 $71.1 Million
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $58 Million - $65 Million
-788,523 Reduced 41.37%
1,117,645 $91.7 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $70.7 Million - $88.6 Million
978,320 Added 105.44%
1,906,168 $146 Million
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $89.5 Million - $98.4 Million
-1,247,958 Reduced 57.36%
927,848 $69.7 Million
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $84.2 Million - $93.2 Million
-1,198,100 Reduced 35.51%
2,175,806 $169 Million
Q1 2021

May 17, 2021

BUY
$68.86 - $81.11 $111 Million - $131 Million
1,616,871 Added 92.02%
3,373,906 $260 Million
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $20 Million - $22.2 Million
278,568 Added 18.84%
1,757,035 $144 Million
Q3 2020

Nov 16, 2020

BUY
$73.18 - $82.95 $5.15 Million - $5.84 Million
70,405 Added 5.0%
1,478,467 $123 Million
Q2 2020

Aug 14, 2020

SELL
$70.42 - $80.13 $43.4 Million - $49.4 Million
-615,909 Reduced 30.43%
1,408,062 $109 Million
Q1 2020

May 15, 2020

BUY
$63.36 - $87.82 $62.6 Million - $86.8 Million
988,086 Added 95.39%
2,023,971 $156 Million
Q4 2019

Feb 18, 2020

BUY
$77.58 - $87.54 $68.1 Million - $76.8 Million
877,489 Added 553.98%
1,035,885 $94.2 Million
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $10.9 Million - $11.9 Million
-143,151 Reduced 47.47%
158,396 $13.3 Million
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $221,113 - $258,313
3,166 Added 1.06%
301,547 $25.3 Million
Q1 2019

May 15, 2019

SELL
$69.58 - $79.36 $4.34 Million - $4.95 Million
-62,341 Reduced 17.28%
298,381 $24.8 Million
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $3.47 Million - $4.02 Million
-53,146 Reduced 12.84%
360,722 $27.6 Million
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $4.82 Million - $5.67 Million
83,534 Added 25.29%
413,868 $29.4 Million
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $892,015 - $1.05 Million
17,549 Added 5.61%
330,334 $20.1 Million
Q1 2018

May 15, 2018

BUY
$50.96 - $59.23 $15.9 Million - $18.5 Million
312,785 New
312,785 $17 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.